Covered recipient · General Payments record
LAURIE A WELTON
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2024
$7,493.71
- Reported across 260 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $342.61 | 16 |
| Education | $10.85 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $149.86 | 7 |
| Insmed, Inc. | $72.84 | 4 |
| Astellas Pharma US Inc | $24.67 | 1 |
| ViiV Healthcare Company | $24.34 | 1 |
| Gilead Sciences, Inc. | $23.38 | 1 |
| Shionogi Inc | $21.34 | 1 |
| Paratek Pharmaceuticals, Inc. | $19.05 | 1 |
| ABBVIE INC. | $17.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.98 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106325535 | CMS |
| Astellas Pharma US Inc | $24.67 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139294082 | CMS |
| Gilead Sciences, Inc. | $23.38 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133642612 | CMS |
| Insmed, Inc. | $15.17 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089577556 | CMS |
| Insmed, Inc. | $16.38 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089562342 | CMS |
| Insmed, Inc. | $15.61 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089571814 | CMS |
| Insmed, Inc. | $25.68 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089565649 | CMS |
| Merck Sharp & Dohme LLC | $20.16 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141555958 | CMS |
| Merck Sharp & Dohme LLC | $16.36 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141908768 | CMS |
| Merck Sharp & Dohme LLC | $20.16 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141908774 | CMS |
| Merck Sharp & Dohme LLC | $27.61 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141555956 | CMS |
| Merck Sharp & Dohme LLC | $29.58 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141555960 | CMS |
| Merck Sharp & Dohme LLC | $10.85 | 08/29/2024 | Education | Undisputed | 01/23/2026 | 1141555834 | CMS |
| Merck Sharp & Dohme LLC | $25.14 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141821753 | CMS |
| Paratek Pharmaceuticals, Inc. | $19.05 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113923450 | CMS |
| Shionogi Inc | $21.34 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154331048 | CMS |
| ViiV Healthcare Company | $24.34 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112746939 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.